Yes — in most cases HPV does clear on its own. About 9 out of 10 infections go away within two years without causing any health problems, as your immune system suppresses the virus CDC. But "clears" isn't the same as "cured," and high-risk types that don't clear are the ones that can become cancer over time.

~42 million
Currently infected
~13 million
New infections / yr
~90%
Clear within 2 years
>90%
Vaccine prevents

of HPV-attributable cancers

HPV in the US at a glance. Source: CDC.
HPV in the US at a glance
ItemValue
Currently infected~42 million
New infections / yr~13 million
Clear within 2 years~90%
Vaccine prevents>90% — of HPV-attributable cancers

Curable or not? The honest answer

HPV is the most common STI, and the way it behaves trips people up. There's no drug that cures the virus the way antibiotics cure chlamydia. Instead, your own immune system usually does the work — most infections are cleared within two years and never cause symptoms or disease. So the practical answer is reassuring for the majority: the body handles it. The catch is the minority of infections that stick around, especially high-risk types, which is what screening exists to catch.

Two different problems get blurred together here. Low-risk types (mainly 6 and 11) cause genital warts; high-risk types (16, 18, and a handful of others) cause cancers. The types that cause warts do not cause cancer — they're separate issues with separate consequences.

What 'cure' actually means here

"Cleared" means the virus is no longer detectable and isn't causing problems — your immune system has driven it down to undetectable levels. That's what happens to most people. "Cured" implies a treatment that eliminates the virus on demand, and that treatment doesn't exist for HPV. You can treat what HPV does — remove warts, treat precancers — but you can't take a pill to wipe out the infection itself.

This distinction matters because someone whose warts were frozen off may think they're done with HPV. They're not necessarily. The visible lesion is gone; the virus may still be present in the surrounding skin, which is why warts can come back.

The treatments that clear lesions (but not the virus)

Treatment targets the visible or detectable disease, not the infection. What you're offered depends on whether you have warts or a precancer found through screening.

Genital warts

Warts can be treated at home with a prescription cream or in a clinic by a provider CDC STI Tx Guidelines. Patient-applied options include imiquimod cream, podofilox solution or gel, and sinecatechins ointment (sinecatechins aren't recommended for people who are immunocompromised or HIV-positive). Provider-administered options include cryotherapy — freezing with liquid nitrogen or a cryoprobe — trichloroacetic or bichloroacetic acid solution, and surgical removal by excision, curettage, laser, or electrosurgery.

In real life, no single method is clearly best. A clinic freezes the warts, or you apply a cream at home over several weeks. Either way, you're removing the growth, not the virus — so warts can recur, sometimes more than once. For more on how warts present and what to expect with treatment, see genital warts in men.

Cancer precursors (precancers)

Abnormal cervical cells found through screening are managed completely separately from warts — never with wart creams. Precancers are monitored or removed before they can progress, which is the entire point of catching them early. This is a different track of care, handled through your gynecologic provider based on screening results.

Even after treating warts or precancer, the virus itself isn't eliminated. Treatment manages the consequences; clearance is still up to your immune system CDC Pink Book.

Why fading symptoms don't mean you're cured

When warts disappear or a Pap comes back normal, it's natural to assume the infection is over. But disappearing symptoms only tell you the disease isn't currently active or visible — not that the virus is gone. High-risk HPV is especially sneaky: it usually causes no symptoms at all, so there's nothing to "fade" in the first place. A persistent high-risk infection can sit silently for years while quietly causing cellular changes.

That's exactly why the goal isn't to feel symptom-free; it's to confirm, through testing, that high-risk types either cleared or aren't causing precancer. Symptom relief and viral clearance are two different milestones.

Follow-up and how HPV is actually detected

For women, current guidance starts cervical screening at age 25 with a primary HPV test every five years as the preferred approach, rather than a yearly Pap American Cancer Society. The longer interval reflects the biology: because most HPV clears on its own within two years, an HPV test catches more real precancer with fewer visits. Your provider tracks whether a high-risk infection persists across visits — persistence, not a single positive result, is the warning sign.

There's no routine HPV test for men. HPV testing isn't recommended for men, and for women HPV is found through cervical screening — not through a general STD panel. So if you're wondering whether a standard panel will tell you your HPV status, it won't. If you're sorting out timing around any exposure, here's when to test after exposure, and you can get tested for other STIs through the same visit.

What happens if a high-risk infection goes untreated

Most infections never reach this point — they clear. The concern is the minority of high-risk infections that persist. Over years, persistent high-risk HPV can progress to cervical, vulvar, vaginal, penile, anal, and oropharyngeal (throat) cancers NCI.

HPV's cancer toll reaches well beyond the cervix. It causes virtually all cervical cancer, over 90% of anal cancers, and about 70% of throat cancers — and oropharyngeal cancer has now overtaken cervical cancer as the most common HPV-related cancer in the US. That shift is part of why prevention matters for everyone, not just people who get cervical screening.

Prevention sits on three legs: vaccination, partial protection from condoms, and cervical screening. Condoms reduce risk but only partially — HPV can infect skin a condom doesn't cover. Screening catches precancer early. And the vaccine prevents the infections in the first place.

The vaccine: prevention, not a cure

The HPV vaccine used in the US today is Gardasil 9, which protects against nine types: 6, 11, 16, 18, 31, 33, 45, 52, and 58 American Cancer Society. Types 16 and 18 cause about 66% of cervical cancers; the five additional high-risk types add roughly another 15%, and types 6 and 11 cause more than 90% of genital warts. Given at the recommended ages, the vaccine can prevent more than 90% of HPV-caused cancers, and Gardasil 9 is about 98% effective against the precancers caused by HPV 16 and 18.

One thing the vaccine does not do is treat an infection or warts you already have — it protects against future infection. Vaccinated people still need cervical screening. If you missed it as a teen, it's still worth discussing; see the hpv vaccine for adults and more detail on eligibility and timing for the hpv vaccine for adults.

Treatment vs. prevention at a glance

ApproachWhat it doesWhat it doesn't do
Immune clearanceResolves most infections within two years on its ownNot guaranteed for persistent high-risk types
Wart treatment (cream, freezing, removal)Removes visible wartsDoesn't remove the virus; warts can recur
Cervical screeningFinds precancer early so it can be treatedDoesn't prevent infection
Gardasil 9 vaccinePrevents future infection with nine HPV typesDoesn't clear an existing infection or warts

When to see a clinician

  • You notice new bumps, warts, or skin changes in the genital, anal, or oral area.
  • You're due for cervical screening, or a previous result was abnormal and needs follow-up.
  • You've had a positive high-risk HPV test and need to know the next step.
  • You want the vaccine and aren't sure whether you're still eligible.
  • Your warts came back after treatment, or treatment isn't working.

If you're choosing where to test for other STIs alongside this, you can compare testing providers to find the right fit.